McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...

In its upcoming report, McKesson (MCK) is predicted by Wall Street analysts to post quarterly earnings of $6.89 per share, reflecting an increase of 10.6% compared to the same period last year.

In terms of liquidity and interest, the mean open interest for McKesson options trades today is 166.17 with a total volume of ...

Irving, Texas-based McKesson Corporation (MCK) provides healthcare services in the U.S. and internationally. With a market ...

The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions ("RxTS"), Medical-Surgical Solutions, and International. McKesson is ...

Sen. Elizabeth Warren calls on FTC to block medical distributors McKesson (MCK) and Cardinal Health's (MCK) recent deals to ...

Arkadios Wealth Advisors boosted its stake in McKesson Co. (NYSE:MCK – Free Report) by 43.7% in the 3rd quarter, according to ...

Integrated Advisors Network LLC lowered its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 3.9% in the 3rd quarter, according to its most recent disclosure with the Securities & ...

Friday, Cardinal Health Inc. (NYSE:CAH) reported first-quarter 2025 adjusted EPS of $1.88, up 9% year over year, beating the ...

not keeping up with the Medical sector's loss of 3.6% and the S&P 500's gain of 1.21%. The investment community will be paying close attention to the earnings performance of McKesson in its ...

Barclays analyst Stephanie Davis maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $616.00. The ...

With a market cap of $65.7 billion, McKesson operates through the U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International segments. It is ...